Basel Medical Group Ltd Ordinary Shares (BMGL) — Cash Flow-to-Debt Ratio
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow-to-Debt Ratio of -0.36x as of June 2025, meaning its operating cash flow of $-4.34 Million could theoretically repay 0% of its total liabilities ($11.99 Million) in one year. Explore BMGL long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Basel Medical Group Ltd Ordinary Shares Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Basel Medical Group Ltd Ordinary Shares across 4 annual periods. Also explore how large is Basel Medical Group Ltd Ordinary Shares's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Basel Medical Group Ltd Ordinary Shares (2022–2025)
Year-by-year debt coverage analysis for Basel Medical Group Ltd Ordinary Shares. For market capitalisation and broader financial context, see Basel Medical Group Ltd Ordinary Shares (BMGL) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.36x | $-4.34 Million | $11.99 Million | ▼ -226.3% |
| 2024 | 0.29x | $2.51 Million | $8.75 Million | ▲ +9.1% |
| 2023 | 0.26x | $2.60 Million | $9.89 Million | ▲ +23.7% |
| 2022 | 0.21x | $2.79 Million | $13.14 Million | — |